8-K: Current report
Apr 17 09:14 ET
Acorda Therapeutics | 8-K: Current report
Apr 4 13:02 ET
Acorda Therapeutics | 8-K: Current report
Apr 2 13:05 ET
Acorda Therapeutics | 10-K: Annual report
Apr 1 17:12 ET
Acorda Therapeutics | 8-K: Current report
Mar 13 16:39 ET
Acorda Therapeutics | 8-K: Current report
Jan 11 00:00 ET
Acorda Therapeutics | 8-K: Current report
Dec 1, 2023 16:30 ET
Acorda Therapeutics: Q3 2023 Earnings Report
Nov 13, 2023 20:41 ET
Acorda Therapeutics | 8-K: Current report
Nov 13, 2023 16:16 ET
Acorda Therapeutics | 10-Q: Q2 2023 Earnings Report
Aug 8, 2023 17:36 ET
Acorda Therapeutics | 8-K: Current report
Aug 8, 2023 16:12 ET
Acorda Therapeutics | 8-K: Current report
Jun 27, 2023 16:35 ET
Acorda Therapeutics | 8-K: Current report
Jun 26, 2023 16:30 ET
Acorda Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BURNS THOMAS M.
Jun 23, 2023 19:59 ET
Acorda Therapeutics | 3: Initial statement of beneficial ownership of securities-Director BURNS THOMAS M.
Jun 23, 2023 19:57 ET
Acorda Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Varian John
Jun 23, 2023 17:38 ET
Acorda Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director PANEM SANDRA PHD
Jun 23, 2023 17:37 ET
Acorda Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kelley John P
Jun 23, 2023 17:36 ET
Acorda Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Jensen Peder
Jun 23, 2023 17:34 ET
Acorda Therapeutics | 8-K: Current report
Jun 2, 2023 16:28 ET
No Data
No Data